Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: The CLEAN-TAVI randomized clinical trial

JAMA - Journal of the American Medical Association

Volumn 316, Issue 6, 2016, Pages 592-601

  Haussig, Stephan ^a   Mangner, Norman ^a   Dwyer, Michael G ^b   Lehmkuhl, Lukas ^a   Lücke, Christian ^a   Woitek, Felix ^a   Holzhey, David M ^a   Mohr, Friedrich W ^a,c   Gutberlet, Matthias ^a   Zivadinov, Robert ^b   Schuler, Gerhard ^a   Linke, Axel ^a,c  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY AT BUFFALO   (United States)

^c University Heart Centre   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; AGED; AORTA STENOSIS; ARTICLE; BRAIN DAMAGE; BRAIN HEMORRHAGE; BRAIN SIZE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; EMBOLIC PROTECTION DEVICE; EMBOLIC PROTECTION FILTER; FATALITY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; NEUROIMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; THORACOTOMY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT RESPONSE; VASCULAR DISEASE; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; ALGORITHM; AORTIC VALVE STENOSIS; BRAIN ISCHEMIA; DOUBLE BLIND PROCEDURE; INTENTION TO TREAT ANALYSIS; NEUROLOGIC EXAMINATION; PROCEDURES; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; ALGORITHMS; AORTIC VALVE STENOSIS; BRAIN ISCHEMIA; DIFFUSION MAGNETIC RESONANCE IMAGING; DOUBLE-BLIND METHOD; EMBOLIC PROTECTION DEVICES; FEMALE; HUMANS; INTENTION TO TREAT ANALYSIS; MALE; NEUROLOGIC EXAMINATION; TIME FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84981201082     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.10302     Document Type: Article

References (22)

1. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597-1607.
2. Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370(19):1790-1798.
3. Linke A, Wenaweser P, Gerckens U, et al. Treatment of aortic stenosis with a self-expanding transcatheter valve. Eur Heart J. 2014;35(38):2672-2684.
4. Ludman PF, Moat N, de Belder MA, et al. Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012. Circulation. 2015;131(13):1181-1190.
5. Miller DC, Blackstone EH, Mack MJ, et al. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg. 2012;143(4):832-843. e13.
6. Généreux P, Head SJ, Van Mieghem NM, et al. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions. J AmColl Cardiol. 2012;59(25):2317-2326.
7. Messé SR, Acker MA, Kasner SE, et al. Stroke after aortic valve surgery. Circulation. 2014;129(22):2253-2261.
8. Kahlert P, Knipp SC, Schlamann M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation. Circulation. 2010;121(7):870-878.
9. Ghanem A, Müller A, Nähle CP, et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation. J AmColl Cardiol. 2010;55(14):1427-1432.
10. Fairbairn TA, Mather AN, Bijsterveld P, et al. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation. Heart. 2012;98(1):18-23.
11. Astarci P, Glineur D, Kefer J, et al. Magnetic resonance imaging evaluation of cerebral embolization during percutaneous aortic valve implantation. Eur J Cardiothorac Surg. 2011;40(2):475-479.
12. Van Mieghem NM, Schipper MEI, Ladich E, et al. Histopathology of embolic debris captured during transcatheter aortic valve replacement. Circulation. 2013;127(22):2194-2201.
13. Naber CK, Ghanem A, Abizaid AA, et al. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation. EuroIntervention. 2012;8(1):43-50.
14. Rodés-Cabau J, Kahlert P, Neumann F-J, et al. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2014;7(10):1146-1155.
15. Lansky AJ, Schofer J, Tchetche D, et al. A prospective randomized evaluation of the TriGuard HDH embolic DEFLECTion device during transcatheter aortic valve implantation. Eur Heart J. 2015;36(31):2070-2078.
16. Hartkamp NS, De Cocker LJ, Helle M, et al. In vivo visualization of the PICA perfusion territory with super-selective pseudo-continuous arterial spin labeling MRI. Neuroimage. 2013;83:58-65.
17. Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal. 2001;5(2):143-156.
18. Jezzard P, Balaban RS. Correction for geometric distortion in echo planar images from B0 field variations. Magn Reson Med. 1995;34(1):65-73.
19. Tay ELW, Gurvitch R, Wijesinghe N, et al. A high-risk period for cerebrovascular events exists after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2011;4(12):1290-1297.
20. Amat-Santos IJ, Rodés-Cabau J, Urena M, et al. Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. J AmColl Cardiol. 2012;59(2):178-188.
21. van Rooij FG, Schaapsmeerders P, Maaijwee NAM, et al. Persistent cognitive impairment after transient ischemic attack. Stroke. 2014;45(8):2270-2274.
22. Goldberg I, Auriel E, Russell D, Korczyn AD. Microembolism, silent brain infarcts and dementia. J Neurol Sci. 2012;322(1-2):250-253.